Member Info for Aldebaran

Wonder what size prints we'll see after hours again. More 6-figure ones will be highly suspicious (in a good way).

Correct i shorted that sh ite at 550p recently and took profit at 500p took the wife away for the weekend.

Zero interest in that shhhh it ty little podcast company which has no USP, waifer thin margins, low barrier to entry and in a cyclical market dependent on nuisance advertisements thanks. Hemo and avacta are revolutionising cancer treatment. There is more upside in these stocks than you can dream of from podcasting mate. So get a life and stop following me about just because I shorted your favourite stock

Ice hes listened to Tom's webcast thing and is parroting that. Which is fine but without scratching the surface avacta is a p1 company with a bloated valuation. You and I and us all both know when you dig a little deeper however there is much more than meats the eye. If he isnt capable or can't be bothered to dig further leave him to put shorts on by hanging onto Tom's every word. I won't be trying to convince him against it or educating him on Avacta. He can find out the hard way. Suggest all take the same stance and just ignore the 🤡

Treasureisland I agree with you. You still short from 30p? Probably a great time to add to it now especially with all the bad news the CEO has said is on its way..if it was a compelling short at 30p then now it must be a slam dunk..take care

Best thing you can do is believe in yourself and put on a whopping great short treasureisland. Your right this is phase 1 and 90% fail. This is probably one of those. You cant lose

Wait, why are people saying that is a sell? Please don't say because it's marked as a sell on here🙈

Looking at the bid/ask at the time id suggest maybe thats more likely to be a buy and given the £0.5m buy yesterday it could be indicative of II stakebuilding

Doesn't seem to be much left in this?

Beerhuntr has repeatedly posted 61.5p was the peak for Avacta. He now thinks a 300k sell which was absorbed without flinching is painful.

I suggest he sticks to his 5th best podcast company audioboom which has waifer thin margins and is grossly overvalued and operating in a crowded sector that has extremely low barriers to entry. Leave avacta to revolutionise the treatment of cancer. 🤡

That post is from Myles.

Also, 300k today and was 456k yesterday.

Something is happening. Price continues to rise. This is going to be epic

Finally, finally, the significance of #AVCT's pre|CISION platform is beginning to sink in with the investment community. A warhead delivery system that looks set to revolutionize oncology.

It just so happens that the first pre|CISION drug, AVA6000, is highly likely to become standard-of-care for salivary gland cancer in the near future, and (in my view) play a key role in combo therapy for breast cancers.

It also just so happens that the second pre|CISION drug, AVA6103, looks like it could easily surpass the leading antibody-drug conjugates on the market and become the world's best-selling oncology drug.

But the crux of the investment case is that pre|CISION is an incredibly flexible, supremely targeted delivery system that can transport an immense range of warheads to >80% of all cancers.

And Avacta is the only company that can use this platform to modify/enhance naked warheads for another two decades - meaning that patent protection over the last pre|CISION drug launched could extend to 2065 (assuming said final modified warhead is itself patented just before expiry of the family patents).

Keeping the company independent beyond 2026 is going to be an incredibly tough ask for mgmt. I am convinced numerous tier 1 pharmas are already all over Avacta.

......

FYI - both the interim presentation, and the latest episode in @avacta's spotlight series, are two must-watch videos published this week - equally for non-holders and for existing investors.

Saint, why didnt you just email the company with your concerns instead of moaning on here?

Seems its ok for those of you in the click to say you would like an update but anyone else is a deramping troll shorter ret hard lol

Also, you keep purposely missing off the caveat I said at the end of all those comments which was that if price broke 180p with volume and/or funding got sorted that would be a strong buy signal. I called it perfectly even calling the top which is what I think really annoys you about me not that I give 2 fks as your just another bulletin board more on who would rather argue with people than debate facts

"It’s at these times that regular updates highlighting the potential are crucial."

Hypocrit.

I didnt say it WOULD drop to a fiver, I said it could if there is a continues news vacuum.

Haha that's quite funny. I just think they do a lot of things better and HEMO can learn from them and implement themselves for the benefit of investors. Both have exceptional science both are undervalued

Till.your right we had updates fine but what about forward looking updates. Investors are in the dark. What are the timelines for key milestones? We just supposed to sit in the dark and not no? I tell you now instituons won't tolerate that and neither will the USA if hemo decide to go that route. You can compare avacta and hemo price over any time frame you like to make either company look better than the other. My point is that both are undervalued by a long way. Avacta management are now driving that valuation UP. Hemo... silence. I think this really ought to be valued much higher and I think that is the CEO job.

If that has become controversial then it shows this board has lost all objectivity.

It's definitely a buy why is it even being debated. Hopefully not the last one either. Could it be an instituon or big pharma starting to take a stake ahead of the imminent 3rd party validating commercial deal?

Is there a news rich period tho because the CEO has not given any visibility of it whatsoever.

Infact we dont even know if the patience on trial are still alive. All he could muster up regarding the clinical progress was that it had been 'good'. 🤣

Needs to do much better, much much better then that to drive value for investors. Or are we all supposed to just invest in the dark with nothing but hopium to keep us sane?

At least the company tho shall not be named gives crystal clear guidance of what milestones to expect and when over the next few months. For the life of me. I do not. Understand why hemo can't do the same and why some posters are seemingly against the idea of transparency from the company. Its really bizarre

Constructivenews is 28 days up yet?

We still waiting

Obviously 🤣

Don't educate him though anyone, just leave him to believe what Tom is spoon feeding him and let him lose the shirt off his back. He can learn the hard way.

I kind of respect Tom is a lot of ways but he has zero clue about biotechs. His recent "analysis" on avacta and Hemo is really really poor. But hes good at assessing other companies within his area of competence

It's sad to want our CEO to come out and drive the value of the company? Come.on JHFH, clearly you see if nothing else that I want this to increase in value and I believe it is chronically undervalued.

2 updates on same day for avacta and hemo. Avacta market cap now rapidly rising and hemo stagnating. Why? Because both have exceptional science. Its because it takes more than that. Especially in this tough market.

Someone just bought almost half a million pound worth of avacta shares today. Why? Because the CEO exudes confidence and has demonstrated a clear timeline of events for us all. I just want the same thing for HEMO. Why is that such a controversial view to hold given the chronic undervaluation of our company?